抗癫痫药物的产妇结局和神经发育影响 (MONEAD)-猫眼课题宝

抗癫痫药物的产妇结局和神经发育影响 (MONEAD)

批准号：

8206070

负责人：

KIMFORD J MEADOR

金额：

$317.13万

依托单位：

EMORY UNIVERSITY

依托单位国家：

美国

项目类别：

财政年份：

2000

资助国家：

美国

项目状态：

已结题

起止时间：

2000-09-30 至 2017-07-31

来源：

https://reporter.nih.gov/project-details/8206070

关键词：

Academy Address Affect Age American Anticonvulsants Antiepileptic Agents Area Benchmarking Blood Blood drug level result Breast Feeding Caring Child Cognitive Cohort Studies Comorbidity Congenital Abnormality Controlled Study Counseling Data Dose Dose-Limiting Drug Exposure Epilepsy Exhibits Exposure to Failure Female of child bearing age Frequencies Funding Future Genetic Goals Grant Guidelines Impairment Incidence Individual Infant Investigation Knowledge Long-Term Effects Major Depressive Disorder Measures Mental Depression Mothers National Institute of Neurological Disorders and Stroke Neonatal Neurology Outcome Patients Perinatal Exposure Pharmacogenetics Postpartum Depression Postpartum Period Pregnancy Pregnancy Outcome Pregnant Women Progress Reports Recording of previous events Regimen Registries Research Resources Risk Risk Factors Safety Sampling Seizures Severities Structure Time Woman adverse outcome clinical practice cohort design high risk human data improved in utero lamotrigine maternal depression nervous system disorder neurobehavioral neurodevelopment novel oxcarbazepine prevent prospective psychosocial response valproate

项目摘要

项目成果

KIMFORD J MEADOR的其他基金

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

DESCRIPTION (provided by applicant): There is a compelling need for prospective, properly controlled studies in women with epilepsy (WWE) during pregnancy to improve maternal and child outcomes. The proposed investigations are pertinent to the NINDS Epilepsy Research Benchmarks and will address multiple gaps in our knowledge noted by the recent American Academy of Neurology guidelines. This multicenter investigation will employ a prospective, observational, parallel-group, cohort design with an established research team. The specific aims are to: 1) Determine if WWE have increased seizures during pregnancy and delineate the contributing factors; 2) Determine if C-section rate is increased in WWE and delineate contributing factors; 3) Determine if WWE have an increased risk for depression during pregnancy and post-partum period and characterize risks factors; 4) Determine the long- term effects of in utero AED exposure on verbal intellectual abilities and other neurobehavioral outcomes in the children of WWE; 5) Determine if small for gestation age and other adverse neonatal outcomes are increased in children of WWE; 6) Determine if breastfeeding when taking AEDs impairs the child's verbal intellectual and other cognitive abilities. An overall goal f the proposed research is to establish the relationship between AED exposure and outcomes in the mother and child as well as describe and explain the variability in AED exposure and response. Anticonvulsant blood levels (ABLs) and area-under-the- concentration-time-curves (AUCs) will be used as direct measures of drug exposure. The results will enable clinicians to prospectively calculate individual dosing regimens for the mother in order to optimize dosing and limit unnecessary drug exposure to the child. In addition, genetic samples will be collected, which will provide a valuable resource for future pharmacogenetics studies to further delineate individual variability across patients.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文